|
|
Volumn 8, Issue 4, 2015, Pages 499-500
|
|
Capturing maximal coronary vasodilation for myocardial perfusion imaging: Is timing everything?
a
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE;
CORONARY VASODILATING AGENT;
NITROGEN 13;
REGADENOSON;
RUBIDIUM 82;
TECHNETIUM 99M;
THALLIUM 201;
ADENOSINE A2 RECEPTOR AGONIST;
DIPYRIDAMOLE;
PURINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
VASODILATOR AGENT;
BRONCHOSPASM;
CORONARY ARTERY DILATATION;
EDITORIAL;
HEART MUSCLE BLOOD FLOW;
HUMAN;
MULTICENTER STUDY (TOPIC);
MYOCARDIAL PERFUSION IMAGING;
PHASE 3 CLINICAL TRIAL (TOPIC);
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
CHEMICALLY INDUCED;
HYPEREMIA;
SENSITIVITY AND SPECIFICITY;
TIME FACTOR;
VASODILATATION;
ADENOSINE A2 RECEPTOR AGONISTS;
DIPYRIDAMOLE;
HUMANS;
HYPEREMIA;
MYOCARDIAL PERFUSION IMAGING;
POSITRON-EMISSION TOMOGRAPHY;
PURINES;
PYRAZOLES;
SENSITIVITY AND SPECIFICITY;
TIME FACTORS;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
VASODILATION;
VASODILATOR AGENTS;
|
|
EID: 84928165522
PISSN: 1936878X
EISSN: 18767591
Source Type: Journal
DOI: 10.1016/j.jcmg.2015.03.002 Document Type: Editorial |
|
Times cited : (7)
|
|
References (4)
|
